Fyr Bio
17 employees on LinkedIn · 1 known investors
FYR develops an AI-enabled multi-omic platform (EV-Omics/EVO) that profiles extracellular vesicles in blood to decode RNA and protein signals for disease detection and characterization. Using its proprietary SPARCs enrichment technology, it supports diagnostics developers, drug developers, and precision medicine programs from biomarker discovery through clinical validation.
Investors · 1
Frequently asked questions
- What does Fyr Bio do?
- FYR develops an AI-enabled multi-omic platform (EV-Omics/EVO) that profiles extracellular vesicles in blood to decode RNA and protein signals for disease detection and characterization. Using its proprietary SPARCs enrichment technology, it supports diagnostics developers, drug developers, and precision medicine programs from biomarker discovery through clinical validation.
- Who are Fyr Bio's investors?
- Fyr Bio's investors include Two Bear Capital.